Ticker LaunchCanada to US · Cross-listing · PROF
Profound Medical Corp.
Profound Medical Corp. (PROF), a Ontario-based company, cross-listed on Nasdaq on Aug 29, 2019, registering its securities on Form 20FR12B.
Profound Medical is an Ontario-based early commercial-stage medical device company that develops and markets customizable, incision-free systems for ablating diseased tissue; its TULSA-PRO system received FDA clearance in August 2019 for prostate tissue ablation.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- PROF
- Listed
- Aug 29, 2019
- Province
- Ontario
- Registration form
- 20FR12B
- Security
- Common shares
- Sector
- Healthcare
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (20FR12B) Aug 29, 2019
- Offering document
- All filings on EDGAR CIK 1628808
Other Canadian companies listing in the US
- Liminal BioSciences Inc.Nasdaq · Nov 12, 2019
- Dirtt Environmental Solutions LtdNasdaq · Sep 20, 2019
- Equinox Gold Corp.NYSE American · Sep 10, 2019
- BELLUS Health Inc.Nasdaq · Sep 3, 2019
- Viemed Healthcare, Inc.Nasdaq · Jul 10, 2019
- Maverix Metals Inc.NYSE American · Jun 7, 2019